Company

We’re one of the largest generics and specialty pharmaceutical companies in the world, manufacturing and marketing more than 1,400 different products to retail, wholesale, government and institutional customers.

We apply one global quality standard across our facilities and​ product line, regardless of market.​

A History of Doing What’s Right

We began in 1961 as a company dedicated to helping people in small West Virginia towns and rural communities gain access to affordable medicine. Today, we remain dedicated to the same mission, but we do it for the world.

  1. 0

    Increasing Generic Utilisation

    We’re actively educating governments around the world about the role generic medicines play in affordable health care and access to medicine.
  2. 0

    One Quality Standard

    Medicines and their ingredients can be made in facilities all over the world. We believe in one global quality standard for all medicines. And we passionately support efforts and legislation that bring us all closer to that goal.
  3. 0

    Driving Biosimilar Access

    Biosimilars are generic equivalents of biologics—expensive medicines for diseases like cancer, multiple sclerosis, rheumatoid arthritis and diabetes. We promote effective biosimilar approval pathways that drive interchangeability, maximise patient access to more affordable, high quality biologics and reduce health care spending.
  • Our Values

    What sets us apart? Innovation, Integrity, Reliability, Service and Teamwork. Living our values is how we can work to provide 7 billion people access to high quality medicine.
    Discover how our values define us
  • Mylan Voices

    • Robert J Coury
      Executive Chairman
      "We have one global quality standard because we know where our priorities are. It all starts and ends with you."
    • Heather Bresch
      Chief Executive Officer
      "Our mission is to provide 7 billion people access to high quality medicine.
      We are determined to put the care back in healthcare."
    • Rajiv Mallik
      President
      "Setting new standards in health care is a promise that Mylan keeps every day."
  • Global Manufacturing

    Our global manufacturing platform continues to grow.

    • 65 billion: Oral solid dose manufacturing capacity
    • 80%: Percentage of our products, by volume, that are manufactured internally
    • >35,000 Worldwide workforce
    • ~165: Countries and territories where our products are available

    We’re also one of the world’s largest suppliers of active pharmaceutical ingredients.

  • Questions?

    Get more information on our products, services and Mylan Global Center locations.
    Contact us

  • Business Opportunities

    Do you have an opportunity or a collaboration idea?
    Partner with us

Last Updated:  5/08/2016